Clinical Cardiology Alert – July 1, 2004
July 1, 2004
View Issues
-
Cardiac-Resynchronization Therapy in Advanced Chronic Heart Failure
In selected patients, cardiac resynchronization therapy with a pacemaker or pacemaker-defibrillator improves their clinical course and the addition of a defibrillator with cardiac resynchronization therapy alone further reduces mortality. -
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Data showed a strong trend toward benefit with ICD therapy in patients with nonischemic cardiomyopathy. -
Pre-Discharge Beta Blockers for Heart Failure
The pre-discharge initiation of beta blocker therapy for decompensated heart failure patients increased the number of patients on beta blockers at 60 days without an increase in length of stay or adverse effects. -
COX-2 Inhibitor Controversy
Current rofecoxib use was associated with a higher risk of acute myocardial infarction or admission for heart failure compared to celecoxib. -
Much More About CRP!
CPR values as a continuous variable have independent predictive value for subsequent coronary events in apparently healthy women. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Britain to Allow Over-the-Counter Sales of Zocor
The British government will soon allow over-the-counter sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin.